Mahmoud, Ramy A.
OptiNose (United States)
9 papers on CoChatORCID 0000-0003-4456-1865
Most cited papers
- Verified
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine
Schizophrenia research and treatmentBipolar Disorder and Treatment
Cited by 605
- Verified
A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently
Macfadden, W., Alphs, L., Haskins, J. T., Turner, N., Turkoz, I., Bossie, C., Kujawa, M., & Mahmoud, R. (2009) · Bipolar Disorders
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 178
- Verified
Risperidone for Treatment-Refractory Major Depressive Disorder: A Randomized Trial
Mahmoud, R. A., Pandina, G. J., Turkoz, I., Kosik-Gonzalez, C., Canuso, C. M., Kujawa, M. J., & Gharabawi-Garibaldi, G. M. (2007) · Annals of Internal Medicine
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 140
- Verified
Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial
Quintana, D. S., Westlye, L. T., Hope, S., Nærland, T., Elvsåshagen, T., Dørum, E., Rustan, Ø., Valstad, M., Rezvaya, L., Lishaugen, H., et al. (2017) · Translational Psychiatry
Neuroendocrine regulation and behaviorAutism Spectrum Disorder Research
Cited by 111
- Verified
Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment
Quintana, D. S., Westlye, L. T., Rustan, Ø. G., Tesli, N., Poppy, C. L., Smevik, H., Tesli, M., Røine, M., Mahmoud, R. A., Smerud, K. T., et al. (2015) · Translational Psychiatry
Neuroendocrine regulation and behaviorOlfactory and Sensory Function Studies
Cited by 103
- Verified
Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial
Quintana, D. S., Westlye, L. T., Alnæs, D., Rustan, Ø. G., Kaufmann, T., Smerud, K. T., Mahmoud, R. A., Djupesland, P. G., & Andreassen, O. A. (2016) · Psychoneuroendocrinology
Neuroendocrine regulation and behaviorOlfactory and Sensory Function Studies
Cited by 102
- Verified
Cognitive Functioning and Acute Sedative Effects of Risperidone and Quetiapine in Patients With Stable Bipolar I Disorder: A Randomized, Double-Blind, Crossover Study
Harvey, P. D., Hassman, H., Mao, L., Gharabawi, G. M., Mahmoud, R. A., & Engelhart, L. M. (2007) · The Journal of Clinical Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 52
- Verified
Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men
Quintana, D. S., Westlye, L. T., Smerud, K. T., Mahmoud, R. A., Andreassen, O. A., & Djupesland, P. G. (2018) · Hormones and Behavior
Neuroendocrine regulation and behaviorOlfactory and Sensory Function Studies
Cited by 52
- Verified
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
Gharabawi, G. M., Gearhart, N. C., Lasser, R. A., Mahmoud, R. A., Zhu, Y., Mannaert, E., Naessens, I., Bossie, C. A., Kujawa, M., & Simpson, G. M. (2007) · Annals of General Psychiatry
Schizophrenia research and treatmentTreatment of Major Depression
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free